Shiwu Zhang

机构：Union Hospital, Nankai University, Tianjin Nankai Hospital, Tianjin Medical University · ORCID：0000-0002-5052-2283

发表论文 231 篇 · 总被引 6778 次 · h-index 49

代表论文

• RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential (2024 · Cancer Cell International · 被引 33)
• The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond (2025 · Drug Resistance Updates · 被引 18)
• Role of the CTCF/p300 axis in osteochondrogenic-like differentiation of polyploid giant cancer cells with daughter cells (2024 · Cell Communication and Signaling · 被引 9)
• Predictive nomogram of the clinical outcomes of colorectal cancer based on methylated SEPT9 and intratumoral IL-10+ Tregs infiltration (2024 · Journal of Translational Medicine · 被引 8)
• 1433P A phase I/II study of FG-M108 plus capecitabine and oxaliplatin (CAPOX) as first-line (1L) treatment for patients with CLDN18.2+/HER2- advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (2024 · Annals of Oncology · 被引 8)
• Dormant and activated polyploid giant cancer cells: From chemoradiotherapy resistance to cancer progression (2025 · Cancer Letters · 被引 7)